16-1204361-A-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_021098.3(CACNA1H):​c.2354A>T​(p.Lys785Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0038 in 1,576,242 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0029 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0039 ( 21 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

2
11
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 1.97

Publications

11 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03796467).
BP6
Variant 16-1204361-A-T is Benign according to our data. Variant chr16-1204361-A-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 460063.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00295 (449/152370) while in subpopulation AMR AF = 0.0049 (75/15312). AF 95% confidence interval is 0.00401. There are 2 homozygotes in GnomAd4. There are 211 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 449 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.2354A>T p.Lys785Met missense_variant Exon 10 of 35 ENST00000348261.11 NP_066921.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.2354A>T p.Lys785Met missense_variant Exon 10 of 35 1 NM_021098.3 ENSP00000334198.7
CACNA1HENST00000569107.6 linkc.2354A>T p.Lys785Met missense_variant Exon 10 of 34 1 ENSP00000454990.2
CACNA1HENST00000711493.1 linkc.2354A>T p.Lys785Met missense_variant Exon 10 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.2354A>T p.Lys785Met missense_variant Exon 10 of 34 1 ENSP00000455840.1
CACNA1HENST00000711450.1 linkc.2354A>T p.Lys785Met missense_variant Exon 10 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.2354A>T p.Lys785Met missense_variant Exon 10 of 35 1 ENSP00000457555.2
CACNA1HENST00000638323.1 linkc.2315A>T p.Lys772Met missense_variant Exon 10 of 35 5 ENSP00000492267.1
CACNA1HENST00000562079.6 linkc.2354A>T p.Lys785Met missense_variant Exon 10 of 34 1 ENSP00000454581.2
CACNA1HENST00000711438.1 linkc.2315A>T p.Lys772Met missense_variant Exon 10 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.2354A>T p.Lys785Met missense_variant Exon 10 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.2354A>T p.Lys785Met missense_variant Exon 10 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.2354A>T p.Lys785Met missense_variant Exon 10 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.2354A>T p.Lys785Met missense_variant Exon 10 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.2354A>T p.Lys785Met missense_variant Exon 10 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.2354A>T non_coding_transcript_exon_variant Exon 10 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.2354A>T non_coding_transcript_exon_variant Exon 10 of 34 5 ENSP00000492650.2
CACNA1HENST00000639478.1 linkn.2354A>T non_coding_transcript_exon_variant Exon 10 of 35 5 ENSP00000491945.1
CACNA1HENST00000640028.1 linkn.*267A>T non_coding_transcript_exon_variant Exon 10 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*1801A>T non_coding_transcript_exon_variant Exon 9 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.2354A>T non_coding_transcript_exon_variant Exon 10 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.2354A>T non_coding_transcript_exon_variant Exon 10 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.2354A>T non_coding_transcript_exon_variant Exon 10 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.2354A>T non_coding_transcript_exon_variant Exon 10 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.2354A>T non_coding_transcript_exon_variant Exon 10 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.2354A>T non_coding_transcript_exon_variant Exon 10 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.2354A>T non_coding_transcript_exon_variant Exon 10 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.2354A>T non_coding_transcript_exon_variant Exon 10 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.2354A>T non_coding_transcript_exon_variant Exon 10 of 35 ENSP00000518777.1
CACNA1HENST00000640028.1 linkn.*267A>T 3_prime_UTR_variant Exon 10 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*1801A>T 3_prime_UTR_variant Exon 9 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
AF:
0.00295
AC:
449
AN:
152252
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000506
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00497
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.00423
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00419
Gnomad OTH
AF:
0.00334
GnomAD2 exomes
AF:
0.00357
AC:
774
AN:
216636
AF XY:
0.00362
show subpopulations
Gnomad AFR exome
AF:
0.000267
Gnomad AMR exome
AF:
0.00357
Gnomad ASJ exome
AF:
0.000862
Gnomad EAS exome
AF:
0.0000577
Gnomad FIN exome
AF:
0.00509
Gnomad NFE exome
AF:
0.00494
Gnomad OTH exome
AF:
0.00426
GnomAD4 exome
AF:
0.00389
AC:
5537
AN:
1423872
Hom.:
21
Cov.:
32
AF XY:
0.00397
AC XY:
2794
AN XY:
704212
show subpopulations
African (AFR)
AF:
0.000460
AC:
15
AN:
32584
American (AMR)
AF:
0.00385
AC:
155
AN:
40292
Ashkenazi Jewish (ASJ)
AF:
0.000851
AC:
20
AN:
23512
East Asian (EAS)
AF:
0.0000254
AC:
1
AN:
39326
South Asian (SAS)
AF:
0.00210
AC:
167
AN:
79612
European-Finnish (FIN)
AF:
0.00498
AC:
251
AN:
50382
Middle Eastern (MID)
AF:
0.000896
AC:
5
AN:
5582
European-Non Finnish (NFE)
AF:
0.00427
AC:
4668
AN:
1093880
Other (OTH)
AF:
0.00434
AC:
255
AN:
58702
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
303
606
908
1211
1514
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00295
AC:
449
AN:
152370
Hom.:
2
Cov.:
33
AF XY:
0.00283
AC XY:
211
AN XY:
74520
show subpopulations
African (AFR)
AF:
0.000505
AC:
21
AN:
41588
American (AMR)
AF:
0.00490
AC:
75
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4834
European-Finnish (FIN)
AF:
0.00423
AC:
45
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00419
AC:
285
AN:
68034
Other (OTH)
AF:
0.00331
AC:
7
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
25
50
74
99
124
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00323
Hom.:
0
Bravo
AF:
0.00294
TwinsUK
AF:
0.00431
AC:
16
ALSPAC
AF:
0.00415
AC:
16
ESP6500AA
AF:
0.000235
AC:
1
ESP6500EA
AF:
0.00331
AC:
28
ExAC
AF:
0.00358
AC:
430
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:4
Feb 20, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Oct 17, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 35350424, 36786913)

Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CACNA1H: BS2

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Benign
-0.087
T
BayesDel_noAF
Uncertain
0.10
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.54
D;.;.;.
Eigen
Uncertain
0.32
Eigen_PC
Benign
0.20
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.80
T;T;T;.
M_CAP
Pathogenic
0.66
D
MetaRNN
Benign
0.038
T;T;T;T
MetaSVM
Uncertain
0.77
D
MutationAssessor
Pathogenic
3.2
M;.;M;M
PhyloP100
2.0
PrimateAI
Uncertain
0.65
T
PROVEAN
Uncertain
-2.8
D;.;D;D
REVEL
Uncertain
0.61
Sift
Uncertain
0.014
D;.;D;D
Sift4G
Uncertain
0.019
D;.;D;D
Vest4
0.72
ClinPred
0.029
T
GERP RS
3.9
Varity_R
0.11
gMVP
0.66
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28365117; hg19: chr16-1254361; COSMIC: COSV62005812; COSMIC: COSV62005812; API